Charles Schwab Investment Management Inc X4 Pharmaceuticals, Inc Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 323,843 shares of XFOR stock, worth $187,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
323,843
Previous 323,843
-0.0%
Holding current value
$187,828
Previous $272,000
65.44%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding XFOR
# of Institutions
106Shares Held
103MCall Options Held
206KPut Options Held
291K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$9.81 Million3.55% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$8.69 Million1.46% of portfolio
-
Black Rock Inc. New York, NY8.74MShares$5.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.83MShares$4.54 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$4.14 Million0.22% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $39.8M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...